Insights – nineonecapital.in

How to Analyse a 100 PE Stock
Source: Nine One Capital Published on 2025-09-24
AI Can Read, It Can’t Infer
Source: Nine One Capital Published on 2025-09-17
Preparing, Not Predicting
Source: Nine One Capital Published on 2025-09-02
Supreme Court’s Stray Dog Ruling: A ₹20 Billion Tailwind for Animal Health Stocks?
Source: Nine One Capital Published on 2025-08-25
What the Indices Don’t Tell You
Source: Nine One Capital Published on 2025-08-15
Cooling Off to Heat Up: Why We’re Studying the AC Sector Now
Source: Nine One Capital Published on 2025-08-10
Unlisted Doesn’t Mean Uncertain: Our Playbook for Investing in Unlisted Companies
Source: Nine One Capital Published on 2025-08-05
RPTs, Governance, and a Path to Rerating
Source: Nine One Capital Published on 2025-07-31
Venus Remedies Annual Reports Analysis
Source: Nine One Capital Published on 2025-07-26
Misunderstood & Mispriced. Investing in IT Products Company
Source: Nine One Capital Published on 2025-07-24
E2E Networks: Reality Bites
Source: Nine One Capital Published on 2025-07-22
Ratnaveer Vs Scoda: A Closer Look at Two Stainless Steel Stocks
Source: Nine One Capital Published on 2025-07-21
Innovation, Turnaround, and Asymmetry: Deep Dive on Venus Remedies Ltd.
Source: Nine One Capital Published on 2025-07-13
India’s Silent Surveillance Shakeup: The $4 Billion Opportunity No One's Watching
Source: Nine One Capital Published on 2025-07-07
How Our Screening Process Identified Narayana Health at an Inflection Point
Source: Nine One Capital Published on 2025-07-01